Conagra Brands FY2026 Q4 Results and FY2027 Outlook
Conagra Brands, Inc. (NYSE:CAG) released its fourth‑quarter fiscal 2026 results, reporting adjusted earnings per share (EPS) of $0.47, marginally above the analyst consensus of $0.46. Revenue for the quarter reached $2.9 billion, a 3.6% year‑over‑year increase and slightly ahead of the $2.89 billion estimate. Organic net sales were essentially flat, with a 1.6% positive price/mix impact offset by a 1.6% decline in volume.
The company provided fiscal 2027 guidance of adjusted EPS between $1.40 and $1.50, with a midpoint of $1.45, which is materially below the Wall Street consensus of $1.70. Conagra also projected organic net sales for fiscal 2027 to decline between 1% and 3% versus fiscal 2026, and expects an adjusted operating margin in the range of 10.0% to 10.5%.
In conjunction with the outlook, Conagra announced a reduction in its annualized dividend to $0.70 per share. The firm expects full‑year fiscal 2026 organic net sales to decline 0.4% after an overall net‑sales decrease of 2.9% to $11.3 billion. Adjusted EPS for the full fiscal year 2026 was $1.72, and the adjusted operating margin fell to 11.3% from the prior year.
A net loss of $1.6 billion, or $3.37 per diluted share, was recorded for the fourth quarter, driven primarily by a $2.0 billion non‑cash goodwill and brand impairment charge linked to a sustained decline in the company’s share price and market capitalization. Despite the loss, Conagra generated $979 million in free cash flow for fiscal 2026 and reduced net debt by 11.9% to $7.1 billion.
Shares fell 3.2% in pre‑market trading following the release of the guidance. "In fiscal 2026, our team delivered results within our guidance ranges, navigating a dynamic operating environment while demonstrating the resilience of our business and disciplined execution across the organization," said John Brase, President and Chief Executive Officer of Conagra Brands.
Key Figures
- Q4 adjusted EPS: $0.47 (consensus $0.46)
- Q4 revenue: $2.9 bn (+3.6% YoY, estimate $2.89 bn)
- FY2027 EPS guidance: $1.40‑$1.50 (midpoint $1.45) vs consensus $1.70
- FY2027 organic net‑sales outlook: down 1%‑3%
- Adjusted operating margin FY2027: 10.0%‑10.5%
- Dividend: reduced to $0.70 per share annually
- FY2026 full‑year adjusted EPS: $1.72; net sales $11.3 bn (‑2.9%)
- FY2026 adjusted operating margin: 11.3%
- Q4 net loss: $1.6 bn ($3.37 per diluted share)
- Impairment charge: $2.0 bn goodwill and brand write‑down
- FY2026 free cash flow: $979 m
- Net debt: $7.1 bn (‑11.9% YoY)
- Pre‑market share reaction: –3.2%